Ionis Pharmaceuticals | IONS - Interest Expense On Debt



Ionis Pharmaceuticals reported $19M in Interest Expense on Debt for its fiscal quarter ending in June of 2025.


Interest Expense On Debt Change Date
Agios Pharmaceuticals 3.01M 10.05M Dec/2024
Alnylam Pharmaceuticals USD 40.25M 1.6M Jun/2025
Arrowhead Research USD 24.38M 2.74M Jun/2025
Astellas Pharma 3.91B 320M Mar/2025
BioMarin Pharmaceutical USD 2.68M 184K Jun/2025
Celltrion KRW 17.04B 1.34B Mar/2025
Cspc Pharmaceutical 10.38M 934K Dec/2024
Divis Laboratories Ltd 30M 20M Jun/2025
Exelixis 23.4M 3.9M Sep/2023
Halozyme Therapeutics USD 4.39M 131K Jun/2025
Ionis Pharmaceuticals USD 19M 0 Jun/2025
Kangmei Pharma CNY 1.67M 1.45M Mar/2025
Knight Therapeutics CAD 1.91M 369K Sep/2024
Laboratorios Farma 699K 666.2K Jun/2025
Medical Developments International AUD 21K 23K Jun/2024
Moderna USD 1000K 0 Jun/2025
Neuren Pharmaceuticals 0 0 Jun/2024
Neurocrine Biosciences USD 1.1M 0 Mar/2024
Novartis USD 289M 19M Jun/2025
OPKO Health USD 70.33M 52.97M Jun/2025
Pfizer USD 654M 0 Jun/2025
PTC Therapeutics USD 30.36M 4.03M Jun/2025
Qiagen NV USD 7.6M 311K Jun/2025
Regeneron Pharmaceuticals USD 3.6M 5.1M Jun/2025
Roche Holding CHF 311.5M 1000K Dec/2024
Sarepta Therapeutics USD 5.23M 725K Jun/2025
Sartorius 41.4M 51.4M Jun/2025
Sino Biopharmaceutical CNY 76.87M 114.23M Jun/2024
Tilray USD 7.77M 2.08M Nov/2024
Ultragenyx Pharmaceutical 14.04M 1.48M Jun/2025
Vertex Pharmaceuticals USD 3.7M 900K Jun/2025
Zz Pientze Pharmaceu 46.05M 36.5M Jun/2025